PodcastIntel
Sign in Get Started Free
The Immune-Mediated Inflammatory Disease Forum
The Immune-Mediated Inflammatory Disease Forum

Author Interview: Doctor Elise van Mulligen, September 2026

Sep 3, 2026 · 0:21:21
Listen to Episode
✨ AI Summary
  • Discussing long-term methotrexate durability for RA risk.
  • Examining anti-citrullinated protein antibody-positive and negative arthralgia.
  • Insights from TREAT EARLIER 5-year randomized trial data.

Guests on This Episode

EM
Elise van Mulligen
researcher · 1 podcast appearance
›

More from The Immune-Mediated Inflammatory Disease Forum

The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Impact of BMI on response to JAK inhibitors in RA
Oct 8, 2026 · 0:07:14
The Immune-Mediated Inflammatory Disease Forum
Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials
Sep 30, 2026 · 0:20:11
The Immune-Mediated Inflammatory Disease Forum
Discussing RA: Biologic effectiveness and treatment persistence in RA
Aug 27, 2026 · 0:08:53
The Immune-Mediated Inflammatory Disease Forum
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety
Aug 20, 2026 · 0:24:23
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to The Immune-Mediated Inflammatory Disease Forum and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →